本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Maravai LifeSciences Holdings, Inc.

6.84
-0.0400-0.58%
成交量:308.09萬
成交額:2,116.17萬
市值:17.76億
市盈率:-12.91
高:7.09
開:6.90
低:6.78
收:6.88
52周最高:9.42
52周最低:2.55
股本:2.60億
流通股本:1.03億
量比:1.12
換手率:2.99%
股息:- -
股息率:- -
每股收益(TTM):-0.5299
每股收益(LYR):-0.9059
淨資產收益率:-33.05%
總資產收益率:-5.71%
市淨率:8.68
市盈率(LYR):-7.55

資料載入中...

2021/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/06

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/05

重要事件披露

8-K - Current report
2021/04/05

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/03/22

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/02

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/25

重要事件披露

8-K - Current report
2020/11/23

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/16

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/16

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/13

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/09

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/29

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933